Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Custom Animal Overexpression Cell Line

Inquiry Now
Gene Synthesis Vector Construction Transfection/Transduction Lentiviral Packaging Positive Cell Clone Screening Relative Development Services Flow Chart Related Research Why Choose Us? Case Study FAQs

BioVenic offers custom animal overexpression cell line services to generate stable cell lines that consistently express target genes, supporting veterinary research, animal gene-function and expression studies, and genetic engineering research. Our platform covers gene synthesis for challenging sequences (repetitive elements, high GC content, hairpins), custom vector construction with sequence optimization and tag insertion (RFP, GFP), transfection and transduction via advanced techniques, lentiviral packaging for hard-to-transfect primary, stem, and non-dividing cells, and positive clone screening through antibiotic selection and monoclonal isolation (limited dilution, flow cytometric sorting). We support researchers with a one-stop workflow from gene synthesis and vector construction through viral packaging, transduction, and monoclonal screening, plus expression validation by FACS, Western blot, and PCR, and cryopreservation to ensure a stable, long-term cell line supply.

Gene Synthesis

Gene synthesis is a crucial step in establishing animal cell lines that consistently express a specific gene. BioVenic offers high-quality gene synthesis services utilizing host cell information and gene sequences provided by our customers. We can efficiently deliver challenging sequences that contain repetitive elements, high GC content, hairpin structures, and consecutive single bases.

Vector Construction

Vector construction ensures that the target gene is efficiently expressed and functions in the host cell. BioVenic offers custom vector construction services on demand. We offer a diverse range of vector systems optimized for various research applications, validated both in vitro and in vivo. Utilizing our service for vector customization and cloning will significantly reduce the time and enhance the efficiency of vector construction.

Sequence Optimization
  • Adjustment of GC content.
  • Eliminate unstable sequences.
  • Optimize codon usage.
Insertion of Specific Sequences
  • RFP Tag.
  • GFP Tag.
  • …

Transfection/Transduction

BioVenic provides transduction and transfection services. We use advanced transfection techniques to introduce target genes into specific cells. For challenging cell types, we utilize special viral vectors or optimized transfection conditions.

Lentiviral Packaging

Lentiviral vectors are increasingly favored for their ability to introduce specific genes into hard-to-transfect cells, including primary and stem cells, as well as non-dividing cells. This capability significantly boosts the success rate of gene transduction. Additionally, lentiviruses offer clear advantages in transient transfection processes and the establishment of stable cell strains. BioVenic offers lentiviral packaging services, providing customers with a variety of options for titer and specifications.

Positive Cell Clone Screening

BioVenic provides services for screening positive cell clones to achieve genetically and phenotypically consistent single-cell clones from transduced cell populations. This is done through antibiotic screening and monoclonal isolation techniques. Cells are exposed to a medium containing a specific antibiotic, and only those containing the resistance gene survive, enabling initial screening. After screening, the cells are separated into individual cells using the limited dilution method or flow cytometric sorting. Each single cell is subsequently cultured in separate wells to form the monoclonal cell population desired by the customer.

Relative Development Services

BioVenic offers services related to screening and validating overexpressing cell lines. This involves verifying gene expression levels and protein function using FACS, Western blot, and PCR. We also offer cell cryopreservation services for our customers. Successfully validated overexpression cell lines will be expanded and properly frozen to ensure a stable long-term supply and reuse.

Flow Chart of Custom Animal Overexpression Cell Line Development

Fig.1 Custom Animal Overexpression Cell Line Development Flow Chart. (BioVenic Original)

Related Research

To evaluate expression platform performance for complex viral antigen production, Liste-Calleja et al. systematically compared three biomanufacturing paradigms in human embryonic kidney 293 (HEK293) cells using the porcine circovirus type 2 capsid protein (Cap-PCV2) as a model target: transient adenoviral vector (rAdV) infection in HEK293-F6 suspension cells, stable cell line generation via polyethylenimine (PEI)-mediated random integration with a bicistronic vector (pIRESpuro3), and targeted chromosomal integration via Recombinase-Mediated Cassette Exchange (RMCE). Quantitative bioprocess metrics revealed that RMCE into pre-characterized genomic hotspots yielded the highest specific cellular productivity, doubling the specific expression observed from illegitimate random integrationand drastically outperforming transient viral infection. However, because the random integration pool adapted readily to high-density suspension culture, it achieved the maximum volumetric productivity 103.14 ng/mLxday versus 64.11 ng/mLxday for adherent RMCE clones). These findings demonstrate that while RMCE offers superior cell-specific yields, standardized molecular insertion, and rapid target gene substitution, industrial bioprocess optimization requires pairing targeted genomic insertion with suspension culture adaptation to maximize overall volumetric throughput.

Fig. 1 Schematic representation of the three approaches studied. (Leticia, 2015) (OA Literature)Fig. 1 Schematic representation of the three approaches studied for CapPCV2 protein production.1

Why Choose Us?

BioVenic can achieve gene overexpression in a wide range of cell types, including some that are difficult to transfect. Whether it is a conventional cell line or specialized primary cells, we can provide solutions.

By utilizing advanced transfection and viral packaging technologies, we can accurately integrate target genes into highly active sites in the genome. These sites are selected to ensure not only high gene expression but also stability and safety of expression.

According to the specific needs of customers, we can customize our service solutions. For your special research needs, our team can provide professional consultation and technical support to ensure the realization of your experimental goals.

Case Study

BioVenic built a custom animal overexpression cell line from gene synthesis and vector construction through lentiviral transduction and positive clone isolation. Screening of single-cell clones derived from the transduced pool revealed mostly low-to-moderate expressers, with a small number of clones rising above the selection threshold—one high-expressing clone was chosen and expanded for further validation. The established line combined strong, stable target-protein expression with a clean monoclonal background, ready for functional studies and long-term cryopreserved supply.

Fig. 2 Case Study (BioVenic Original)Fig. 2 Clone Screening

Frequently Asked Questions

Q: What types of animal host cell lines are available for custom overexpression projects?

A: We routinely work with a wide range of standard animal cell lines commonly used in veterinary and biomedical research, including porcine, bovine, canine, feline, and avian origins, as well as general mammalian lines. If your specific research requires a unique or rare cell background, please consult our technical support team to confirm feasibility and availability.

Q: How should I provide the target gene information or sequence for overexpression?

A: Clients can provide the full-length gene sequence, accession numbers from public databases, or pre-cloned plasmids containing the gene of interest. We also offer gene synthesis and codon optimization services if you only have protein sequence data. For detailed vector requirements and submission formats, please contact our technical support staff for guidance.

Q: What expression systems and selection markers do you typically use?

A: We utilize versatile viral vectors (such as lentivirus or retrovirus) and non-viral transfection methods driven by robust constitutive or inducible promoters, paired with common selection markers like puromycin, hygromycin, or fluorescent tags. The optimal vector and promoter configuration depends on your downstream applications. Feel free to consult our technical support for customized design strategies.

Q: How do you validate the successful establishment of the overexpression cell line?

A: Each custom cell line undergoes rigorous quality control, including confirmation of stable integration via PCR, validation of mRNA transcription levels via RT-qPCR, and verification of target protein expression using Western blot or flow cytometry. For specific functional assays or additional validation requirements, please reach out to our technical support team to discuss tailored options.

Q: What is the typical turnaround time and what deliverables can I expect at the end of the project?

A: The standard project timeline generally ranges from a few weeks to a couple of months, depending on the host cell type, cloning complexity, and validation stringency. Upon completion, you will receive a comprehensive project report alongside several stable cell vials and optional positive control samples. For precise scheduling regarding your project, we recommend consulting our technical support team directly.

BioVenic offers custom animal overexpression cell line services, meeting veterinary research needs for animal-specific gene expression studies. We provide a one-stop solution from gene synthesis, vector construction, and viral packaging, to cell transduction and monoclonal screening, utilizing state-of-the-art genetic engineering technologies. If you are seeking a research partner to develop overexpression cell lines, please do not hesitate to contact us.

Reference

  1. Liste-Calleja, Leticia, et al. "Hek293 as a recombinant protein factory: three different approaches for protein production." BMC Proceedings. Vol. 9. No. Suppl 9. London: BioMed Central, 2015. https://doi.org/10.1186/1753-6561-9-S9-P74. Used under CC BY 4.0. Without Modification.
Inquiry Basket
Advertisement